The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia
Official Title: CREEK is a Multicenter Retrospective Study to Understand the Clinical Characteristics, Treatment Pathway and Resource Utilization for Patients With Chronic Lymphocytic Leukemia in International Region.
Study ID: NCT04964908
Brief Summary: A Multicenter Retrospective Study to understand the clinical characteristics, treatment pathway and resource utilization for patients with chronic lymphocytic leukemia A retrospective, multi-centre, observational study to describe disease characteristics, treatment patterns, treatment-related outcomes, and resource utilization for Chronic Lymphocytic Leukemia (CLL) patients in multiple international regions
Detailed Description: CREEK is a retrospective, observational, registry-based study including patients with an incidental diagnosis of CLL and started treatment (1st line, 2nd line, or Subsequent lines of treatment) within the period between 01 June 2016 and 12 months before data collection as identified from the patient records (from participating hospitals across the GCC States and the International region countries) with at least 12 months of follow-up, after starting on treatment. Moreover, the study will include a pilot cohort in the GCC as an exploratory objective to describe the clinical and patient characteristics for the treatment-naive CLL patient
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Ciudad Autonoma de Buenos Aires, , Argentina
Research Site, Ciudad Autonoma de Buenos Aires, , Argentina
Research Site, Campinas, , Brazil
Research Site, Jau, , Brazil
Research Site, Sao Paulo, , Brazil
Research Site, Sao Paulo, , Brazil
Research Site, Sao Paulo, , Brazil
Research Site, Providencia, , Chile
Research Site, Bogota, , Colombia
Research Site, Cali, , Colombia
Research Site, Medellin, , Colombia
Research Site, San Jose, , Costa Rica
Research Site, Santo Domingo. D.N., , Dominican Republic
Research Site, Alexandria, , Egypt
Research Site, Cairo, , Egypt
Research Site, Cairo, , Egypt
Research Site, Cairo, , Egypt
Research Site, Cairo, , Egypt
Research Site, Luxor, , Egypt
Research Site, Ahmedabad, , India
Research Site, Delhi, , India
Research Site, Delhi, , India
Research Site, Faridabad, , India
Research Site, Haryana, , India
Research Site, Hyderabad, , India
Research Site, Kashmir, , India
Research Site, Kolkata, , India
Research Site, Manipal, , India
Research Site, Mumbai, , India
Research Site, Kuwait City, , Kuwait
Research Site, Johor Bahru, , Malaysia
Research Site, Kuala Lumpur, , Malaysia
Research Site, Selangor, , Malaysia
Research Site, Selangor, , Malaysia
Research Site, Ciudad de Mexico, , Mexico
Research Site, Monterrey, , Mexico
Research Site, Panama City, , Panama
Research Site, Jeddah, , Saudi Arabia
Research Site, Riyadh, , Saudi Arabia
Research Site, Riyadh, , Saudi Arabia
Research Site, Singapore, , Singapore
Research Site, Singapore, , Singapore
Research Site, Singapore, , Singapore
Research Site, Taichung, , Taiwan
Research Site, Taipei City, , Taiwan
Research Site, Adana/Saricam, , Turkey
Research Site, Ankara/Altindag, , Turkey
Research Site, Ankara/Yenimahalle, , Turkey
Research Site, Izmir/ Bornova, , Turkey
Research Site, Izmir/Balcova, , Turkey
Research Site, Samsun/Atakum, , Turkey
Research Site, Abu Dhabi, , United Arab Emirates